Dongbang Medical Income Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Revenue	111,855	105,114	90,875	81,408
Revenue Growth (YoY)	9.21%	15.67%	11.63%	-
Cost of Revenue	74,955	71,020	60,134	58,887
Gross Profit	36,900	34,094	30,741	22,520
Selling, General & Admin	17,865	14,821	11,972	11,240
Research & Development	2,727	2,591	2,100	1,798
Amortization of Goodwill & Intangibles	254.06	252.13	241.12	370.93
Other Operating Expenses	434.4	361.01	286.9	572.2
Operating Expenses	22,874	18,618	13,560	16,961
Operating Income	14,026	15,476	17,182	5,560
Interest Expense	-1,254	-1,956	-2,613	-1,308
Interest & Investment Income	325.67	201.48	86.23	40.72
Earnings From Equity Investments	-	-	45.53	-
Currency Exchange Gain (Loss)	470.65	1,080	-202.05	734.38
Other Non Operating Income (Expenses)	-604.94	-9,270	-1,182	1,159
EBT Excluding Unusual Items	12,964	5,532	13,317	6,186
Gain (Loss) on Sale of Investments	-1,013	-727.67	-709.31	-537.95
Gain (Loss) on Sale of Assets	347.47	1,986	-102.65	-28.47
Pretax Income	12,298	6,791	12,505	5,619
Income Tax Expense	2,851	3,663	2,771	2,300
Earnings From Continuing Operations	9,447	3,127	9,734	3,320
Minority Interest in Earnings	169.04	-212.84	40.46	-127.95
Net Income	9,616	2,914	9,775	3,192
Net Income to Common	9,616	2,914	9,775	3,192
Net Income Growth	213.45%	-70.19%	206.26%	-
Shares Outstanding (Basic)	21	16	15	15
Shares Outstanding (Diluted)	21	16	17	15
Shares Change (YoY)	32.33%	-7.51%	17.90%	-
EPS (Basic)	461.93	180.07	658.62	215.05
EPS (Diluted)	461.93	180.07	617.82	215.05
EPS Growth	115.36%	-70.85%	187.29%	-
Free Cash Flow	-4,630	5,408	1,811	4,379
Free Cash Flow Per Share	-219.98	334.19	103.53	295.08
Gross Margin	32.99%	32.44%	33.83%	27.66%
Operating Margin	12.54%	14.72%	18.91%	6.83%
Profit Margin	8.60%	2.77%	10.76%	3.92%
Free Cash Flow Margin	-4.14%	5.15%	1.99%	5.38%
EBITDA	20,725	21,640	22,630	10,832
EBITDA Margin	18.53%	20.59%	24.90%	13.31%
D&A For EBITDA	6,699	6,164	5,448	5,272
EBIT	14,026	15,476	17,182	5,560
EBIT Margin	12.54%	14.72%	18.91%	6.83%
Effective Tax Rate	23.18%	53.95%	22.16%	40.92%
Advertising Expenses	-	1,446	994.74	482.08

Source: S&P Global Market Intelligence. Standard template. Financial Sources.